Neviah Genomics

Neviah Genomics focuses on the discovery and development of novel biomarkers for the prediction of drug-induced toxicity.

Based based in Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA), Neviah Genomics works in genetics.

The company sits in the genetics segment, where it competes on its core product or service.

The company is recorded as being based in Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA).

Its current recorded stage is Private company.

Website: neviahgenomics.com